All In Biotech

Drug Trial Radar · NCT00959569

Esmolol in Cardiac Surgery

Esmolol in Cardiac Surgery. A Randomized Controlled Trial With Clinical

Last checked: Nov 19, 2026Latest source record: Oct 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Aug 2009

Primary completion

May 2018

Study completion Jun 2018

Sponsor

Lead sponsor
Università Vita-Salute San RaffaeleAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 14, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This large randomized double-blind clinical trial (esmolol vs placebo) will enroll patients undergoing cardiac surgery to study the additive cardiac protection of this therapeutic strategy.

Conditions

  • Cardiac Surgery

Interventions

  • EsmololDrug

    esmolol (1-3 mg/kg) during cardiac surgery

  • PlaceboDrug

    normosaline (same ml of the study drug)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite endpoint of number of dead patients and/or number of patients requiring prolonged ICU stay.Time frame: Hospital stay (approximately 2 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vita-Salute University

    Milan, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.